This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Depression  • Psychopharmacology  • Alert me on articles by topic  Social Bookmarking   What's this?

Andrew J. Saxon, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I would like to make 2 points regarding the informative and important article by Dunlop and Nemeroff¹ on the role of dopamine in the pathophysiology of depression.

First, although their article alludes to this concept, the authors do not specifically state that norepinephrine transporters in prefrontal cortex remove dopamine from the synapse.^2-3 Because of the ability of norepinephrine transporters to remove dopamine, blockade of these transporters by agents such as desipramine can acutely increase dopamine levels in the brain.⁴ Of course the long-term effects of this action remain unknown, but it should encourage clinicians to consider more strongly older, currently neglected antidepressants like desipramine in cases of depression that do not respond to other pharmacologic agents.

Second, the authors fail to cite an equally groundbreaking review article on the same topic published 15 years ago.⁵ While brain science has advanced remarkably during the intervening years, many . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLE

The Role of Dopamine in the Pathophysiology of Depression
Boadie W. Dunlop and Charles B. Nemeroff
Arch Gen Psychiatry. 2007;64(3):327-337.
EXTRACT | FULL TEXT